InMed PharmaceuticalsINM 
$4.406.26%24h
6.26%24h
Global rank25985
Market cap$10.77M
Change 7d-13.95%
YTD Performance999.75%
SP500 benchmarkOutperform
P/E-1.35
P/S2.60
Revenue$4.14M
Earnings-$7.95M
Dividend yield-
Main Sector
Healthcare
InMed Pharmaceuticals (INM) Net Assets
INM Net Assets in 2023: $12.09M
As of 23 Dec 2024, InMed Pharmaceuticals net assets is $12.09M, an increase of 33.17% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the InMed Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
InMed Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
INM Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $12.09M | 33.17% |
| 2022 | $9.08M | 23.07% |
| 2021 | $7.38M | 68.22% |
| 2020 | $4.39M | 90.29% |
| 2019 | $2.30M | - |
View the Top Net Assets Companies
